Clinical Trials Logo

Elevated Blood Pressure clinical trials

View clinical trials related to Elevated Blood Pressure.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06376812 Not yet recruiting - Clinical trials for Elevated Blood Pressure

No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women

Start date: May 2026
Phase: N/A
Study type: Interventional

This study will test the effects of a physical activity intervention among midlife Hispanic women.

NCT ID: NCT06348225 Not yet recruiting - Clinical trials for Elevated Blood Pressure

Post-exercise Hot Water Immersion to Improve Overnight Blood Pressure

ExHT
Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test whether putting your legs in a hot bath after exercise improves blood pressure in people with higher blood pressure. . The main questions it aims to answer are: - Whether exercise alone, hot water leg bath alone, or both treatments together cause blood pressure to be lower during sleep. - If there are any changes in heart rhythm or blood vessel health after exercise, hot water leg bath, or the two treatments together that relate to changes in blood pressure. Participants will complete four different trials: - 30 minutes of walking with a 45-minute lukewarm leg bath after - 30 minutes of walking with a 45-minute hot leg bath after - 45 minutes of a hot leg bath with no exercise - A day with no exercise or leg bath Researchers will look at their heart rhythm, blood vessels, and blood pressure after each of these trials to see if there are differences, and if exercise and heat together can improve heart health more than exercise or heat alone.

NCT ID: NCT03804801 Not yet recruiting - Clinical trials for Elevated Blood Pressure

Effect of Hibiscus Sabdariffa on Blood Pressure in a University Population

Start date: February 1, 2019
Phase: Phase 4
Study type: Interventional

Hypertension, also known as high blood pressure, is a very common disease and is considered "the silent killer". Hypertension is responsible for at least 45% of deaths due to heart disease, and 51% of deaths due to stroke. Hypertension plays a part in the worry of heart disease, stroke and kidney failure and premature mortality and disability. If hypertension goes uncontrolled, in the long term, it will cause serious complications, most of which will necessitate costly interventions to be solved and managed. Apparently, these interventions may include cardiac bypass surgery, carotid artery surgery and dialysis, draining individual and government budgets. Recent studies show that hibiscus (Hibiscus sabdariffa) tea can lower blood pressure as effectively as some standard anti-hypertensive drugs can. Hibiscus is widely consumed around the world as a ruby-colored, lemony beverage. Hibiscus is safe and, unlike most blood pressure drugs, rarely causes side effects. All of the studies the investigators found in the literature were either underpowered or inconclusive. All of these studies recommended further studies with bigger samples to accurately assess the effect of hibiscus sabdariffa on blood pressure in hypertensive patients. The aim of this study is to assess the feasibility of a large-scale study assessing the effectiveness of Hibiscus sabdariffa on lowering blood pressure in individuals with elevated blood pressure.

NCT ID: NCT03764020 Not yet recruiting - Clinical trials for Elevated Blood Pressure

Trial of Oral Melatonin in Elevated Blood Pressure

MRCTEBP
Start date: June 1, 2019
Phase: Phase 3
Study type: Interventional

Since, lowering blood pressure (BP) in elevated blood pressure individuals represents an excellent opportunity to for primary prevention of hypertension (HTN). Therefore, it is planned to use a safe treatment option - oral melatonin supplementation - associated with lifestyle interventions according to the American college of cardiology/American heart association (ACC/AHA) 2013 guideline in elevated blood pressure individuals to mitigate systolic and diastolic BP and ultimately, to prevent the development of HTN. Hypothesis: Melatonin therapy can lower the systolic and diastolic BP of elevated blood pressure individuals Melatonin can attenuate levels of circulatory biomarkers of Hs- CRP, Cholesterol, LDL-c and triglyceride